Heritage Cannabis Holdings Corp., through its subsidiaries, operates as a cannabinoid company that focuses on the production and sale of medical and recreational hemp-based and cannabis-based products and services in Canada and the United States.
Price History & Performance
|Historical stock prices|
|Current Share Price||CA$0.065|
|52 Week High||CA$0.045|
|52 Week Low||CA$0.22|
|1 Month Change||-7.14%|
|3 Month Change||-23.53%|
|1 Year Change||-50.00%|
|3 Year Change||-72.92%|
|5 Year Change||85.71%|
|Change since IPO||-78.33%|
Recent News & Updates
Is Heritage Cannabis Holdings (CSE:CANN) A Risky Investment?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
|CANN||CA Pharmaceuticals||CA Market|
Return vs Industry: CANN underperformed the Canadian Pharmaceuticals industry which returned 2% over the past year.
Return vs Market: CANN underperformed the Canadian Market which returned 36.5% over the past year.
Stable Share Price: CANN is more volatile than 90% of Canadian stocks over the past 3 months, typically moving +/- 17% a week.
Volatility Over Time: CANN's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
Heritage Cannabis Holdings Corp., through its subsidiaries, operates as a cannabinoid company that focuses on the production and sale of medical and recreational hemp-based and cannabis-based products and services in Canada and the United States. It offers extraction services; and focuses on processing, manufacturing, and distributing medical cannabis products and cannabis oils. It provides integrative approach to cannabinoid therapy for healthcare consumers and healthcare practitioners.
Heritage Cannabis Holdings Fundamentals Summary
|CANN fundamental statistics|
Is CANN overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|CANN income statement (TTM)|
|Cost of Revenue||CA$6.19m|
Last Reported Earnings
Jul 31, 2021
Next Earnings Date
|Earnings per share (EPS)||-0.025|
|Net Profit Margin||-180.56%|
How did CANN perform over the long term?See historical performance and comparison
Is Heritage Cannabis Holdings undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate CANN's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate CANN's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: CANN is unprofitable, so we can't compare its PE Ratio to the Canadian Pharmaceuticals industry average.
PE vs Market: CANN is unprofitable, so we can't compare its PE Ratio to the Canadian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate CANN's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: CANN is good value based on its PB Ratio (0.5x) compared to the CA Pharmaceuticals industry average (2.4x).
How is Heritage Cannabis Holdings forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Forecasted annual revenue growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if CANN's forecast earnings growth is above the savings rate (1.6%).
Earnings vs Market: Insufficient data to determine if CANN's earnings are forecast to grow faster than the Canadian market
High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: CANN's revenue (87.1% per year) is forecast to grow faster than the Canadian market (6.7% per year).
High Growth Revenue: CANN's revenue (87.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CANN's Return on Equity is forecast to be high in 3 years time
How has Heritage Cannabis Holdings performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CANN is currently unprofitable.
Growing Profit Margin: CANN is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: CANN is unprofitable, and losses have increased over the past 5 years at a rate of 42.7% per year.
Accelerating Growth: Unable to compare CANN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CANN is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (115.1%).
Return on Equity
High ROE: CANN has a negative Return on Equity (-20.09%), as it is currently unprofitable.
How is Heritage Cannabis Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: CANN's short term assets (CA$27.1M) exceed its short term liabilities (CA$5.7M).
Long Term Liabilities: CANN's short term assets (CA$27.1M) do not cover its long term liabilities (CA$30.6M).
Debt to Equity History and Analysis
Debt Level: CANN's debt to equity ratio (6.3%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if CANN's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CANN has sufficient cash runway for 3 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: CANN is forecast to have sufficient cash runway for 2 months based on free cash flow estimates, but has since raised additional capital.
What is Heritage Cannabis Holdings's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate CANN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CANN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if CANN's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CANN's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of CANN's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. David Werner-Paul Schwede has been a Director of Heritage Cannabis Holdings Corp. since August 2021. He has been the Chief Executive Officer of Heritage Cannabis Holdings Corp. since August 2021. He se...
Experienced Management: CANN's management team is not considered experienced ( 0.6 years average tenure), which suggests a new team.
Experienced Board: CANN's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 65.7%.
Heritage Cannabis Holdings Corp.'s employee growth, exchange listings and data sources
- Name: Heritage Cannabis Holdings Corp.
- Ticker: CANN
- Exchange: CNSX
- Founded: 2007
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: CA$51.017m
- Shares outstanding: 784.88m
- Website: https://www.heritagecann.com
Number of Employees
- Heritage Cannabis Holdings Corp.
- 77 Bloor Street West
- Suite 600
- M5S 1M2
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/26 22:40|
|End of Day Share Price||2021/10/26 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.